Wanbury DuPont analysis

Profitability Growth Credit Liquidity Working capital Dividend yield DuPont CAGR

Per cent unless marked ×

Tap a line for its trend	Last 12Mto Jun 2026	FY26Mar 2026	FY25Mar 2025	FY24Mar 2024	FY23Mar 2023	FY22 and earlierAlpha Plus

5-step DuPont — ROE = tax burden × interest burden × EBIT margin × turnover × leverage						FY22 and earlierEvery year the company has filed comes with Alpha Plus.
	1.10×	1.11×	1.03×	0.99×	1.01×
	0.61×	0.65×	0.47×	0.54×	−0.95×
	12.8%	14.2%	10.5%	9.9%	2.2%
	1.40×	1.40×	1.58×	1.78×	1.53×
	3.58×	3.58×	6.98×	12.29×	−41.64×
	43.0%	51.0%	56.2%	115.6%	132.5%
	64.9%	64.9%	70.0%	294.0%	410.0%

Open the chart

From the company's filings with NSE and BSE (Ind-AS), standalone. For information only, not investment advice.

alphave

WANBURY₹181.93

Wanbury Limited

· Pharma & Health

₹ CrorePeersAHCL ANUHPHR BAJAJHCARE THEMISMED ZIMLAB LINCOLN SIGACHI VALIANTLABMcap ₹636 Cr

Profitability Growth Credit Liquidity Working Capital Yield Analysis DuPont

Ratios — % unless marked × 12 Months Ending	FY23 31/03/2023	FY24 31/03/2024	FY25 31/03/2025	FY26 31/03/2026	Last 12M 30/06/2026
5-Step DuPont — ROE = Tax Burden × Interest Burden × EBIT Margin × Turnover × Leverage
Tax Burden (Net Income/Pretax) ×	1.01	0.99	1.03	1.11	1.10
Interest Burden (Pretax/EBIT) ×	-0.95	0.54	0.47	0.65	0.61
EBIT Margin %	2.16	9.90	10.51	14.22	12.85
Asset Turnover ×	1.53	1.78	1.58	1.40	1.40
Financial Leverage (Assets/Equity) ×	-41.64	12.29	6.98	3.58	3.58
ROE (5-step product, year-end total equity) %	132.55	115.56	56.19	51.03	42.96
ROE (owners' profit / average owners' equity) %	409.98	293.97	70.01	64.93	64.93

No consensus estimates → no Est columns. Click any row to chart it.

« ‹ › »Latest: FY26 · StandaloneFA Financial Analysis · alphave

Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.